Significant 2023 milestones highlighted by successful Nasdaq listing, leadership team buildout, formation of strategic development and scientific plan
On track to initiate Phase 2 study.
Zura Bio Limited , a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders, today announced two abstracts were accepted and.
Astria Therapeutics, Inc. , a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that it will share STAR-0215 Phase 1a.
Alergología del Regional se reacredita como centro de excelencia de la Organización Mundial de Alergia malagahoy.es - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from malagahoy.es Daily Mail and Mail on Sunday newspapers.